Post-approval studies (Phase 4)Ended earlyNCT03226899
What this trial is testing
Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
Who this might be right for
GoutChronic Kidney Disease (CKD)
Ironwood Pharmaceuticals, Inc. 242